BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27614953)

  • 1. Epidemiology and Early Detection of Cervical Cancer.
    Hillemanns P; Soergel P; Hertel H; Jentschke M
    Oncol Res Treat; 2016; 39(9):501-6. PubMed ID: 27614953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
    Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
    Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV testing and vaccination in Europe.
    Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
    J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.
    McKenna M; McMenamin MM
    Cancer Cytopathol; 2014 Sep; 122(9):702-10. PubMed ID: 24888573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
    Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
    Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early detection of cervical cancer in Germany: evidence and implementation].
    Seifert U; Klug SJ
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):294-301. PubMed ID: 24562703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
    Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
    Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer Screening: What's New? Updates for the Busy Clinician.
    Zhang S; McNamara M; Batur P
    Am J Med; 2018 Jun; 131(6):702.e1-702.e5. PubMed ID: 29408216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.
    Hillemanns P; Friese K; Dannecker C; Klug S; Seifert U; Iftner T; Hädicke J; Löning T; Horn L; Schmidt D; Ikenberg H; Steiner M; Freitag U; Siebert U; Sroczynski G; Sauerbrei W; Beckmann MW; Gebhardt M; Friedrich M; Münstedt K; Schneider A; Kaufmann A; Petry KU; Schäfer APA; Pawlita M; Weis J; Mehnert A; Fehr M; Grimm C; Reich O; Arbyn M; Kleijnen J; Wesselmann S; Nothacker M; Follmann M; Langer T; Jentschke M
    Geburtshilfe Frauenheilkd; 2019 Feb; 79(2):160-176. PubMed ID: 30792546
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
    Hillemanns P; Friese K; Dannecker C; Klug S; Seifert U; Iftner T; Hädicke J; Löning T; Horn L; Schmidt D; Ikenberg H; Steiner M; Freitag U; Siebert U; Sroczynski G; Sauerbrei W; Beckmann MW; Gebhardt M; Friedrich M; Münstedt K; Schneider A; Kaufmann A; Petry KU; Schäfer APA; Pawlita M; Weis J; Mehnert A; Fehr M; Grimm C; Reich O; Arbyn M; Kleijnen J; Wesselmann S; Nothacker M; Follmann M; Langer T; Jentschke M
    Geburtshilfe Frauenheilkd; 2019 Feb; 79(2):148-159. PubMed ID: 30792545
    [No Abstract]   [Full Text] [Related]  

  • 16. [WHO Guideline for Screening and Treatment of Cervical Pre-Cancerous Lesions for Cervical Cancer Prevention (Second Edition)].
    Harlfinger J; Sommer I; Gartlehner G
    Gesundheitswesen; 2023 Jul; 85(7):630-634. PubMed ID: 37437562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes to cervical cancer screening in Germany].
    Starrach T; Gallwas J; Blankenstein T; Mahner S; Dannecker C
    MMW Fortschr Med; 2018 Feb; 160(2):46-51. PubMed ID: 29417509
    [No Abstract]   [Full Text] [Related]  

  • 18. An emerging paradigms on cervical cancer screening methods and devices for clinical trails.
    Raimond K; Rao GB; Juliet S; Tamilarasi SRG; Evangelin PS; Mathew L
    Front Public Health; 2022; 10():1030304. PubMed ID: 36388384
    [No Abstract]   [Full Text] [Related]  

  • 19. A Change of Paradigm in the Treatment of Cervical Cancer.
    Mallmann P
    Oncol Res Treat; 2016; 39(9):500. PubMed ID: 27614447
    [No Abstract]   [Full Text] [Related]  

  • 20. First cervical cancer vaccine--from pipe dream to pipeline.
    Indian J Med Sci; 1999 Oct; 53(10):454-5. PubMed ID: 10776503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.